BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25051022)

  • 1. Thermal ablation in renal cell carcinoma management: a comprehensive review.
    Wagstaff P; Ingels A; Zondervan P; de la Rosette JJ; Laguna MP
    Curr Opin Urol; 2014 Sep; 24(5):474-82. PubMed ID: 25051022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel methods for renal tissue ablation.
    Olweny EO; Cadeddu JA
    Curr Opin Urol; 2012 Sep; 22(5):379-84. PubMed ID: 22706069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal ablation of small renal masses: intermediate outcomes from a Canadian center.
    Erdeljan P; Dhar M; Wignall G; Kozak R; Pautler SE
    Can J Urol; 2011 Oct; 18(5):5903-7. PubMed ID: 22018153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
    Kunkle DA; Uzzo RG
    Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on ablative therapies of renal tumors.
    D'Andrea D; Shariat SF; Klatte T
    Curr Opin Urol; 2016 Sep; 26(5):410-6. PubMed ID: 27214581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
    Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
    J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
    El Dib R; Touma NJ; Kapoor A
    BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours.
    Jahangeer S; Forde P; Soden D; Hinchion J
    Cancer Treat Rev; 2013 Dec; 39(8):862-71. PubMed ID: 23601905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
    Ma Y; Bedir S; Cadeddu JA; Gahan JC
    BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local thermal ablation of renal cell carcinoma.
    Feng B; Liang P
    Eur J Radiol; 2012 Mar; 81(3):437-40. PubMed ID: 21239130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive surgery using ablative modalities for the localized renal mass.
    Kimura M; Baba S; Polascik TJ
    Int J Urol; 2010 Mar; 17(3):215-27. PubMed ID: 20070411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on thermal ablation of renal cell carcinoma: oncologic control, technique comparison, renal function preservation, and new modalities.
    Zagoria RJ; Childs DD
    Curr Urol Rep; 2012 Feb; 13(1):63-9. PubMed ID: 22076695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model.
    Kroeze SG; van Melick HH; Nijkamp MW; Kruse FK; Kruijssen LW; van Diest PJ; Bosch JL; Jans JJ
    BJU Int; 2012 Sep; 110(6 Pt B):E281-6. PubMed ID: 22612555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron-sparing probe ablative therapy: long-term outcomes.
    Matin SF; Ahrar K
    Curr Opin Urol; 2008 Mar; 18(2):150-6. PubMed ID: 18303535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
    Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
    Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.
    Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR
    BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.